84 related articles for article (PubMed ID: 25339562)
1. Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study.
Goljan-Geremek A; Bednarek M; Franczuk M; Puścińska E; Nowiński A; Czystowska M; Kamiński D; Korzybski D; Stokłosa A; Kowalska A; Wojda E; Sliwiński P; Burakowska B; Ptak J; Barańska I; Drygalska A; Małek G; Bestry I; Wesołowski S; Kram M; Górecka D
Pneumonol Alergol Pol; 2014; 82(6):518-33. PubMed ID: 25339562
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: A single center real-world study.
Fang C; Zhang Q; Wang N; Jing X; Xu Z
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):217-227. PubMed ID: 32476957
[TBL] [Abstract][Full Text] [Related]
3. REFRACTORY PULMONARY SARCOIDOSIS: INCIDENCE AFTER TREATMENT WITH METHYLPREDNISOLONE AND/OR METHOTREXATE IN PATIENTS WITH NEWLY DIAGNOSED DISEASE.
Gavrysyuk V; Merenkova I; Dziublyk Y; Gumeniuk G; Gumeniuk M
Georgian Med News; 2023; (340-341):143-147. PubMed ID: 37805888
[TBL] [Abstract][Full Text] [Related]
4. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
Sweiss NJ; Noth I; Mirsaeidi M; Zhang W; Naureckas ET; Hogarth DK; Strek M; Caligiuri P; Machado RF; Niewold TB; Garcia JG; Pangan AL; Baughman RP
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Apr; 31(1):46-54. PubMed ID: 24751453
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study.
Janssen Bonás M; Sundaresan J; Keijsers RGM; Struys EA; Peters BJM; Kahlmann V; Wijsenbeek MS; de Rotte MCFJ; Grutters JC; Veltkamp M
Lung; 2023 Dec; 201(6):617-624. PubMed ID: 37973683
[TBL] [Abstract][Full Text] [Related]
6. Decreased serpin C1 in extracellular vesicles predicts response to methotrexate treatment in patients with pulmonary sarcoidosis.
Kraaijvanger R; Janssen Bonás M; Grutters JC; Paspali I; Veltkamp M; de Kleijn DPV; van Moorsel CHM
Respir Res; 2024 Apr; 25(1):166. PubMed ID: 38627696
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period.
Baughman RP; Cremers JP; Harmon M; Lower EE; Drent M
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(3):e2020001. PubMed ID: 33264378
[TBL] [Abstract][Full Text] [Related]
8. Musculoskeletal and pulmonary outcomes of sarcoidosis after initial presentation of osseous involvement.
Miller ER; Fanta CH; McSparron JI; Pan B; Coblyn JS; Sparks JA
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):60-73. PubMed ID: 30918438
[TBL] [Abstract][Full Text] [Related]
9. The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis.
Judson MA; Chaudhry H; Louis A; Lee K; Yucel R
Respir Med; 2015 Apr; 109(4):526-31. PubMed ID: 25698652
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Function in Pulmonary Sarcoidosis.
Yao Q; Ji Q; Zhou Y
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959167
[TBL] [Abstract][Full Text] [Related]
11. High-dose (40 mg)
Dhooria S; Sehgal IS; Agarwal R; Muthu V; Prasad KT; Dogra P; Debi U; Garg M; Bal A; Gupta N; Aggarwal AN
Eur Respir J; 2023 Sep; 62(3):. PubMed ID: 37690784
[TBL] [Abstract][Full Text] [Related]
12. RISK FACTORS FOR GC-RESISTANT PULMONARY SARCOIDOSIS.
Ostrovskyy MM; Shvets KV; Kulynych-Miskiv MO; Savelikhina IO; Varunkiv OI; Korzh GZ; Zuban AB
Wiad Lek; 2023; 76(9):1949-1954. PubMed ID: 37898930
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatment in sarcoidosis: Experience over two decades.
Fernández-Ramón R; Gaitán-Valdizán JJ; González-Mazón I; Sánchez-Bilbao L; Martín-Varillas JL; Martínez-López D; Demetrio-Pablo R; González-Vela MC; Ferraz-Amaro I; Castañeda S; González-Gay MA; Blanco R
Eur J Intern Med; 2023 Feb; 108():60-67. PubMed ID: 36446677
[TBL] [Abstract][Full Text] [Related]
14. Oral Methotrexate Treatment of Delayed-Onset Inflammatory Reactions to Dermal Fillers.
Landau M; Silikovich F; Fida M; Cartier H; Kroumpouzos G
Aesthet Surg J Open Forum; 2024; 6():ojae011. PubMed ID: 38690015
[TBL] [Abstract][Full Text] [Related]
15. The impact of low-dose methotrexate on erectile dysfunction, sex hormone profile and spermiogram in male patients with psoriasis: a prospective study.
Atas H; Yüksek T; Karakoyunlu AN; Kartal SP; Taş Aygar G
Cutan Ocul Toxicol; 2024 Jun; ():1-6. PubMed ID: 38810266
[TBL] [Abstract][Full Text] [Related]
16. D. Geraint James Lecture: The sarcoidosis saga: what insights from the past will guide us in the future.
Baughman RP; Lower E
Sarcoidosis Vasc Diffuse Lung Dis; 2023 Dec; 40(4):e2023057. PubMed ID: 38126494
[TBL] [Abstract][Full Text] [Related]
17. A Promising Biomarker for Pulmonary Sarcoidosis That Must Cross the Finish Line.
Maier L; Drake WP
Am J Respir Crit Care Med; 2024 May; ():. PubMed ID: 38748223
[No Abstract] [Full Text] [Related]
18. Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies.
Bonifazi M; Bravi F; Gasparini S; La Vecchia C; Gabrielli A; Wells AU; Renzoni EA
Chest; 2015 Mar; 147(3):778-791. PubMed ID: 25340385
[TBL] [Abstract][Full Text] [Related]
19. Prolonged use of methotrexate for sarcoidosis.
Lower EE; Baughman RP
Arch Intern Med; 1995 Apr; 155(8):846-51. PubMed ID: 7717793
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study.
Migita K; Arai T; Jiuchi Y; Izumi Y; Iwanaga N; Kawahara C; Suematsu E; Miyamura T; Tsutani H; Kawabe Y; Matsumura R; Mori S; Ohshima S; Yoshizawa S; Suenaga Y; Ogushi F; Kawabata M; Furukawa H; Matsui T; Bito S; Tohma S
Medicine (Baltimore); 2014 Nov; 93(26):e175. PubMed ID: 25474431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
